What CLOVER HEALTH INVESTMENTS, CORP. /DE's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 17 | 29 |
| Total trades | 19 | 96 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 96 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Thornton Joseph Clay | Interim CFO | Aug 17 | Sale for tax withholding · S | −17,775 | $4.39 | −$78K | 1,249,526 |
| Thornton Joseph Clay | Interim CFO | Aug 12 | Grant / award · A | +54,347 | — | — | 1,267,301 |
| Soares Karen | Chief Legal Officer | Aug 12 | Grant / award · A | +108,695 | — | — | 1,614,217 |
| Toy Andrew | Chief Executive Officer | Aug 10 | Sale for tax withholding · S | −87,798 | $4.65 | −$408K | 9,459,316 |
| Soares Karen | Chief Legal Officer | Jul 20 | Disclosed 10b5-1 sale · S | −51,700 | $4.51 | −$233K | 1,505,522 |
| Reynoso Jamie L. | CEO, Medicare Advantage | Jul 17 | Disclosed 10b5-1 sale · S | −4,839 | $4.53 | −$21.9K | 2,814,640 |
| Thornton Joseph Clay | Interim CFO | Jul 15 | Sale for tax withholding · S | −4,630 | $4.67 | −$21.6K | 1,212,954 |
| Soares Karen | Chief Legal Officer | Jul 15 | Sale for tax withholding · S | −10,519 | $4.67 | −$49.1K | 1,557,222 |
| Reynoso Jamie L. | CEO, Medicare Advantage | Jul 15 | Sale for tax withholding · S | −13,119 | $4.67 | −$61.3K | 2,819,479 |
| Wai Conrad | CEO, Counterpart Health | Jul 15 | Sale for tax withholding · S | −24,215 | $4.67 | −$113K | 1,145,699 |
| Toy Andrew | Chief Executive Officer | Jul 15 | Sale for tax withholding · S | −62,711 | $4.67 | −$293K | 9,547,114 |
| Reynoso Jamie L. | CEO, Medicare Advantage | Jul 08 | Disclosed 10b5-1 sale · S | −2,384 | $4.68 | −$11.2K | 2,832,598 |
| Reynoso Jamie L. | CEO, Medicare Advantage | Jul 06 | Open-market sale · S | −6,229 | $5.26 | −$32.8K | 2,834,982 |
| Toy Andrew | Chief Executive Officer | Jul 01 | Sale for tax withholding · S | −313,476 | $5.32 | −$1.67M | 9,609,825 |
| Reynoso Jamie L. | CEO, Medicare Advantage | Jun 17 | Disclosed 10b5-1 sale · S | −2,360 | $4.78 | −$11.3K | 2,841,211 |
| Oldakowski Joseph Frank | VP OF FINANCE AND CONTROLLER | Jun 16 | Open-market sale · S | −12,102 | $4.86 | −$58.8K | 299,067 |
| Soares Karen | Chief Legal Officer | Jun 15 | Open-market sale · S | −4,681 | $4.61 | −$21.6K | 1,567,741 |
| Reynoso Jamie L. | CEO, Medicare Advantage | Jun 15 | Open-market sale · S | −6,350 | $4.61 | −$29.3K | 2,843,571 |
| Reynoso Jamie L. | CEO, Medicare Advantage | Jun 11 | Disclosed 10b5-1 sale · S | −7,289 | $4.91 | −$35.8K | 2,849,921 |
| Wai Conrad | CEO, Counterpart Health | May 28 | Disclosed 10b5-1 sale · S | −220,426 | $3.99 | −$879K | 1,390,056 |
Loading...